270 related articles for article (PubMed ID: 24465532)
1. Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania.
Ngarina M; Tarimo EA; Naburi H; Kilewo C; Mwanyika-Sando M; Chalamilla G; Biberfeld G; Ekstrom AM
PLoS One; 2014; 9(1):e85310. PubMed ID: 24465532
[TBL] [Abstract][Full Text] [Related]
2. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study.
Lyatuu GW; Mwashemele SZ; Urrio R; Naburi H; Kashmir N; Machumi L; Kibao A; Sellah Z; Ulenga N; Orsini N; Biberfeld G; Kilewo C; Ekström AM
Lancet HIV; 2021 May; 8(5):e256-e265. PubMed ID: 33581776
[TBL] [Abstract][Full Text] [Related]
3. Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in Tanzania.
Ngarina M; Popenoe R; Kilewo C; Biberfeld G; Ekstrom AM
BMC Public Health; 2013 May; 13():450. PubMed ID: 23647555
[TBL] [Abstract][Full Text] [Related]
4. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Patient Dissatisfaction with Services for Prevention of Mother-To-Child Transmission of HIV in Dar es Salaam, Tanzania.
Naburi H; Mujinja P; Kilewo C; Bärnighausen T; Orsini N; Manji K; Biberfeld G; Sando D; Geldsetzer P; Chalamila G; Ekström AM
PLoS One; 2016; 11(10):e0165121. PubMed ID: 27768731
[TBL] [Abstract][Full Text] [Related]
6. Uptake of guidelines on prevention of mother-to-child transmission of HIV in rural Tanzania: time for change.
Gamell A; Letang E; Jullu B; Mwaigomole G; Nyamtema A; Hatz C; Battegay M; Tanner M
Swiss Med Wkly; 2013; 143():w13775. PubMed ID: 23519621
[TBL] [Abstract][Full Text] [Related]
7. Impact of an innovative approach to prevent mother-to-child transmission of HIV--Malawi, July 2011-September 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Mar; 62(8):148-51. PubMed ID: 23446514
[TBL] [Abstract][Full Text] [Related]
8. Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.
Kilewo C; Karlsson K; Ngarina M; Massawe A; Lyamuya E; Swai A; Lipyoga R; Mhalu F; Biberfeld G;
J Acquir Immune Defic Syndr; 2009 Nov; 52(3):406-16. PubMed ID: 19730269
[TBL] [Abstract][Full Text] [Related]
9. Exploring the acceptability of Option B plus among HIV-positive Nigerian women engaged and not engaged in the prevention of mother-to-child transmission of HIV cascade: a qualitative study.
Erekaha SC; Cornelius LJ; Bessaha ML; Ibrahim A; Adeyemo GD; Fadare M; Charurat M; Ezeanolue EE; Sam-Agudu NA
SAHARA J; 2018 Dec; 15(1):128-137. PubMed ID: 30253709
[TBL] [Abstract][Full Text] [Related]
10. Why did I stop? And why did I restart? Perspectives of women lost to follow-up in option B+ HIV care in Dar es Salaam, Tanzania.
Sariah A; Rugemalila J; Protas J; Aris E; Siril H; Tarimo E; Urassa D
BMC Public Health; 2019 Aug; 19(1):1172. PubMed ID: 31455306
[TBL] [Abstract][Full Text] [Related]
11. Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study.
Kilewo C; Karlsson K; Massawe A; Lyamuya E; Swai A; Mhalu F; Biberfeld G;
J Acquir Immune Defic Syndr; 2008 Jul; 48(3):315-23. PubMed ID: 18344879
[TBL] [Abstract][Full Text] [Related]
12. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
[TBL] [Abstract][Full Text] [Related]
13. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
[TBL] [Abstract][Full Text] [Related]
14. WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
Ciaranello AL; Perez F; Maruva M; Chu J; Engelsmann B; Keatinge J; Walensky RP; Mushavi A; Mugwagwa R; Dabis F; Freedberg KA;
PLoS One; 2011; 6(6):e20224. PubMed ID: 21655097
[TBL] [Abstract][Full Text] [Related]
15. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
16. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
[TBL] [Abstract][Full Text] [Related]
17. Vertical HIV transmission within 18 months post partum among women on lifelong antiretroviral therapy for HIV in Dar es Salaam, Tanzania: a prospective cohort study.
Lyatuu GW; Urrio R; Naburi H; Lyaruu P; Simba B; Siril H; Philipo E; Machumi L; Kibao A; Kajoka D; Nyamhagatta M; Sando D; Biberfeld G; Orsini N; Kilewo C; Ekström AM
Lancet HIV; 2023 Jan; 10(1):e33-e41. PubMed ID: 36495896
[TBL] [Abstract][Full Text] [Related]
18. An assessment of option B implementation for the prevention of mother to child transmission in Dschang, Cameroon: results from the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) cohort.
Altan AM; Taafo F; Fopa F; Buonomo E; Marazzi MC; Nielsen-Saines K; Orlando S; Scarcella P; Ciccacci F; Mancinelli S; Lio MM; Palombi L
Pan Afr Med J; 2016; 23():72. PubMed ID: 27217896
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral drugs to prevent mother-to-child transmission of HIV during breastfeeding.
Shetty AK; Maldonado Y
Curr HIV Res; 2013 Mar; 11(2):102-25. PubMed ID: 23432487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
